420 related articles for article (PubMed ID: 22692785)
1. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
2. Computerized morphometric analysis of pathological prion protein deposition in scrapie-infected hamster brain.
Maximova OA; Taffs RE; Pomeroy KL; Piccardo P; Asher DM
J Histochem Cytochem; 2006 Jan; 54(1):97-107. PubMed ID: 16148313
[TBL] [Abstract][Full Text] [Related]
3. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
4. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
[TBL] [Abstract][Full Text] [Related]
5. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
Zaborowski A
Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
[TBL] [Abstract][Full Text] [Related]
6. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
7. Preclinical deposition of pathological prion protein PrPSc in muscles of hamsters orally exposed to scrapie.
Thomzig A; Schulz-Schaeffer W; Kratzel C; Mai J; Beekes M
J Clin Invest; 2004 May; 113(10):1465-72. PubMed ID: 15146244
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
Prusiner SB
Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
[TBL] [Abstract][Full Text] [Related]
9. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
10. Scrapie-specific neuronal lesions are independent of neuronal PrP expression.
Jeffrey M; Goodsir CM; Race RE; Chesebro B
Ann Neurol; 2004 Jun; 55(6):781-92. PubMed ID: 15174012
[TBL] [Abstract][Full Text] [Related]
11. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases.
Schulz-Schaeffer WJ; Tschöke S; Kranefuss N; Dröse W; Hause-Reitner D; Giese A; Groschup MH; Kretzschmar HA
Am J Pathol; 2000 Jan; 156(1):51-6. PubMed ID: 10623653
[TBL] [Abstract][Full Text] [Related]
12. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
Xanthopoulos K; Paspaltsis I; Apostolidou V; Petrakis S; Siao CJ; Kalpatsanidis A; Grigoriadis N; Tsaftaris A; Tsirka SE; Sklaviadis T
Neurobiol Dis; 2005 Nov; 20(2):519-27. PubMed ID: 15922607
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of pathological prion protein PrPSc in the skin of animals with experimental and natural scrapie.
Thomzig A; Schulz-Schaeffer W; Wrede A; Wemheuer W; Brenig B; Kratzel C; Lemmer K; Beekes M
PLoS Pathog; 2007 May; 3(5):e66. PubMed ID: 17530923
[TBL] [Abstract][Full Text] [Related]
15. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
16. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
17. Prion inactivation by the Maillard reaction.
Suyama K; Yoshioka M; Akagawa M; Murayama Y; Horii H; Takata M; Yokoyama T; Mohri S
Biochem Biophys Res Commun; 2007 Apr; 356(1):245-8. PubMed ID: 17336934
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein-immunoreactive deposits in human and animal prion diseases.
Haïk S; Privat N; Adjou KT; Sazdovitch V; Dormont D; Duyckaerts C; Hauw JJ
Acta Neuropathol; 2002 May; 103(5):516-20. PubMed ID: 11935269
[TBL] [Abstract][Full Text] [Related]
19. Tetracyclines affect prion infectivity.
Forloni G; Iussich S; Awan T; Colombo L; Angeretti N; Girola L; Bertani I; Poli G; Caramelli M; Grazia Bruzzone M; Farina L; Limido L; Rossi G; Giaccone G; Ironside JW; Bugiani O; Salmona M; Tagliavini F
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10849-54. PubMed ID: 12149459
[TBL] [Abstract][Full Text] [Related]
20. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.
Korth C; Kaneko K; Groth D; Heye N; Telling G; Mastrianni J; Parchi P; Gambetti P; Will R; Ironside J; Heinrich C; Tremblay P; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4784-9. PubMed ID: 12684540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
